معرفی
Kim Annink is a researcher at the University Medical Center Utrecht, affiliated with the Faculty of Medicine and the Department of Neonatology. Her work focuses on neonatal hypoxic-ischemic encephalopathy, cerebellar injury, and advanced MRI techniques in infants. She collaborates extensively with multidisciplinary teams in clinical pharmacology and pediatric neurology.
- Role: Researcher in neonatal neurology and pharmacokinetics
- Key Collaborations: Manon Benders, Jeroen Dudink, Floris Groenendaal
Research Interests: Kim investigates brain injury patterns in term neonates, particularly Purkinje cell injury in the cerebellar vermis, and explores pharmacokinetic/pharmacodynamic models for neuroprotective drugs like allopurinol. Her work bridges MRI imaging, renal function assessment, and biomarker analysis in hypoxic-ischemic encephalopathy.
Recent Publications: Her 2023 study on ultra-high-field MRI in infants and 2021 articles on mammillary body atrophy, allopurinol modeling, and glomerular filtration rate quantification highlight her focus on neonatal brain development and therapeutic monitoring.
Contact: Email: kannink@umcutrecht.nl
